View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/SAMHSA RIN: 0930-AA14 Publication ID: Fall 2008 
Title: ●Opioid Drugs in Maintenance or Detoxification Treatment of Opiate Addition(Section 610 Review) 
Abstract: This proposed rule, when finalized will modify the regulatory dispensing restrictions under 42 CFR part 8 for the drug substance buprenorphine. This medication is used to treat kersin and other opioid addiction. 
Agency: Department of Health and Human Services(HHS)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: No  Unfunded Mandates: No 
RFA Section 610 Review: Section 610 Review 
CFR Citation: 42 CFR 8-12     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: 21 USC 823 (9)    42 USC 257a    42 USC 290aa(d)    42 USC 290dd-2    42 USC 300xx-23    42 USC 300x-27(a)    42 USC 300y-11   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  To Be Determined    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: Yes 
Agency Contact:
Nicholas Reuter
Supervising Public Health Advisor
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
Suite 2-1063, One Choke Cherry Road,
Rockville, MD 20857
Phone:240 276-2716
Email: nicholas.reuter@samhsa.hhs.gov